Bio-Techne Corp (TECH) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-techne Corp.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:03.560 Good morning and welcome to Biotechne's 00:00:03.560 -- 00:00:08.180 earnings conference call for the fourth quarter in fiscal year 2025. 00:00:08.180 -- 00:00:12.540 At this time all participants have been placed in a listen-only mode. 00:00:12.540 -- 00:00:17.140 And the call will be open for questions following management's prepared remarks. 00:00:17.140 -- 00:00:21.800 During our Q&A session, please limit yourself to one question and one follow-up. 00:00:21.800 -- 00:00:27.260 I would now like to turn the call over to David Clare, Biotechne's Vice President Investor 00:00:27.260 -- 00:00:28.480 Relations. 00:00:28.480 -- 00:00:30.620 Good morning and thank you for joining us. 00:00:30.620 -- 00:00:35.480 On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, 00:00:35.480 -- 00:00:39.000 and Jim Hippel, Chief Financial Officer of Biotechne. 00:00:39.000 -- 00:00:43.200 Before we begin, let me briefly cover our Safe Harbor Statement. 00:00:43.200 -- 00:00:46.940 Some of the comments made during this conference call may be considered forward-looking 00:00:46.940 -- 00:00:52.180 statements, including beliefs and expectations about the company's future results. 00:00:52.180 -- 00:00:57.380 The company's 10-K for fiscal year 2024 identifies certain factors that could 00:00:57.380 -- 00:01:02.600 cause the company's actual results to differ materially from those projected in the forward-looking 00:01:02.600 -- 00:01:07.840 statements made during this call. The company does not undertake to update any forward-looking 00:01:07.840 -- 00:01:12.380 statements because of any new information or future events or developments. 00:01:12.380 -- 00:01:17.320 The 10-K, as well as the company's other SEC filings...